Anna Nespolo

3PUBLICATIONS
24CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Sep 02, 2026
CDK12/13 inhibition overcomes platinum resistance by impairing RNA metabolism.

|Mar 28, 2026
Dual inhibition of mTOR and HSP90 enhances cisplatin efficacy and overcomes resistance in ovarian cancer.

Rita Lombardi, Laura Addi, Biagio Pucci

|Nov 13, 2024
USP1 deubiquitinates PARP1 to regulate its trapping and PARylation activity.

Anna Nespolo, Linda Stefenatti, Ilenia Pellarin

Pageof 1

Frequent Collaborators

3 joint publications

Gustavo Baldassarre

2 joint publications

Javad Karimbayli

1 joint publications

Linda Stefenatti

1 joint publications

Ilenia Pellarin